» Articles » PMID: 33498218

Directed Mutational Strategies Reveal Drug Binding and Transport by the MDR Transporters of

Overview
Journal J Fungi (Basel)
Date 2021 Jan 27
PMID 33498218
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Multidrug resistance (MDR) transporters belonging to either the ATP-Binding Cassette (ABC) or Major Facilitator Superfamily (MFS) groups are major determinants of clinical drug resistance in fungi. The overproduction of these proteins enables the extrusion of incoming drugs at rates that prevent lethal effects. The promiscuity of these proteins is intriguing because they export a wide range of structurally unrelated molecules. Research in the last two decades has used multiple approaches to dissect the molecular basis of the polyspecificity of multidrug transporters. With large numbers of drug transporters potentially involved in clinical drug resistance in pathogenic yeasts, this review focuses on the drug transporters of the important pathogen . This organism harbors many such proteins, several of which have been shown to actively export antifungal drugs. Of these, the ABC protein Cdr1 and the MFS protein Mdr1 are the two most prominent and have thus been subjected to intense site-directed mutagenesis and suppressor genetics-based analysis. Numerous results point to a common theme underlying the strategy of promiscuity adopted by both Cdr1 and Mdr1. This review summarizes the body of research that has provided insight into how multidrug transporters function and deliver their remarkable polyspecificity.

Citing Articles

ITS Genotype VIII/ Infection and Antifungal Resistance in Bangladesh.

Bhuiyan M, Verma S, Illigner G, Uhrlass S, Klonowski E, Burmester A J Fungi (Basel). 2024; 10(11).

PMID: 39590687 PMC: 11595601. DOI: 10.3390/jof10110768.


Strain Expressed Constitutively High Levels of Sterol 14-α Demethylase mRNA, While Transporter and mRNA Expression Was Induced After Addition of Short Chain Azoles.

Berstecher N, Burmester A, Gregersen D, Tittelbach J, Wiegand C J Fungi (Basel). 2024; 10(11).

PMID: 39590650 PMC: 11595479. DOI: 10.3390/jof10110731.


Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms.

Peng Y, Lu Y, Sun H, Ma J, Li X, Han X Nat Commun. 2024; 15(1):7722.

PMID: 39242571 PMC: 11379888. DOI: 10.1038/s41467-024-52107-w.


Role of ERG11 and MDR1 genes in cycloheximide and multidrug resistance in Candida species.

Huma Z, Saleem S, Imran M, Raza S, Jabeen K, Arshad F Braz J Microbiol. 2024; 55(3):2569-2579.

PMID: 38980650 PMC: 11405649. DOI: 10.1007/s42770-024-01436-5.


Outbreaks: Current Status and Future Perspectives.

De Gaetano S, Midiri A, Mancuso G, Avola M, Biondo C Microorganisms. 2024; 12(5).

PMID: 38792757 PMC: 11123812. DOI: 10.3390/microorganisms12050927.


References
1.
Fling M, Kopf J, Tamarkin A, Gorman J, Smith H, Koltin Y . Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet. 1991; 227(2):318-29. DOI: 10.1007/BF00259685. View

2.
Lockhart S, Etienne K, Vallabhaneni S, Farooqi J, Chowdhary A, Govender N . Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2016; 64(2):134-140. PMC: 5215215. DOI: 10.1093/cid/ciw691. View

3.
Johnson Z, Chen J . ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1. Cell. 2018; 172(1-2):81-89.e10. DOI: 10.1016/j.cell.2017.12.005. View

4.
Holmes A, Keniya M, Ivnitski-Steele I, Monk B, Lamping E, Sklar L . The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Antimicrob Agents Chemother. 2011; 56(3):1508-15. PMC: 3294898. DOI: 10.1128/AAC.05706-11. View

5.
Redhu A, Khandelwal N, Banerjee A, Moreno A, Falson P, Prasad R . pHluorin enables insights into the transport mechanism of antiporter Mdr1: R215 is critical for drug/H+ antiport. Biochem J. 2016; 473(19):3127-45. DOI: 10.1042/BCJ20160407. View